These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 5880954)
41. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka. Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092 [No Abstract] [Full Text] [Related]
42. [Incidence of hepatic changes in relation to the isoniazid acetylator phenotype]. Pilheu JA; De Salvo MC; Manchinu I; de Negroni NR; Szemzo J Medicina (B Aires); 1980; 40(4):382-6. PubMed ID: 7207170 [No Abstract] [Full Text] [Related]
43. [Experimental and clinical study of a new product resulting from the interaction of isoniazid with p-aminosalicylic acid]. KOURILSKY R; KOURILSKY S; MICOULAUD S Therapie; 1954; 9(3):273-92. PubMed ID: 13205512 [No Abstract] [Full Text] [Related]
44. [Determination of isoniazid, PAS and ethionamide in urine]. Svinchuk VS Probl Tuberk; 1983 Apr; (4):64-6. PubMed ID: 6866976 [No Abstract] [Full Text] [Related]
46. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans. Rasmussen SN; Bondesen S; Hvidberg EF; Hansen SH; Binder V; Halskov S; Flachs H Gastroenterology; 1982 Nov; 83(5):1062-70. PubMed ID: 7117789 [TBL] [Abstract][Full Text] [Related]
47. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation. Dubbels R; Kattner E; Sell-Maurer D; Schloot W Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028 [TBL] [Abstract][Full Text] [Related]
48. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid. Ylitalo P; Auterinen L; Marttinen A; Koivula T Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440 [TBL] [Abstract][Full Text] [Related]
49. Examination of the physical chemical basis for the isoniazid-p-aminosalicylic acid combination. REINSTEIN JA; HIGUCHI T J Am Pharm Assoc Am Pharm Assoc; 1958 Oct; 47(10):749-52. PubMed ID: 13587308 [No Abstract] [Full Text] [Related]
50. [Treatment of tuberculous meningitis with the p-amino-salicylate of isoniazid (Dipasic)]. ALONSO LOMAS L; ARIAS MARTINEZ J; AGOTE POVEDA IP Med Esp; 1960 Aug; 44():125-32. PubMed ID: 13682657 [No Abstract] [Full Text] [Related]
51. [Intravenous injection of isoniazid and PAS twice weekly to outpatients with tuberculosis in rural areas]. Ursov IG; Volokitin FN; Borovinskaia TA Probl Tuberk; 1983 Nov; (11):42-5. PubMed ID: 6675002 [No Abstract] [Full Text] [Related]
52. Bioavailability of aminosalicylic acid and its various salts in humans IV: comparison of four brands of the sodium salt. Pentikäinen PJ; Wan SH; Azarnoff DL J Pharm Sci; 1974 Sep; 63(9):1431-4. PubMed ID: 4610119 [No Abstract] [Full Text] [Related]
53. [Isonicotinic acid hydrazide, PAS and T-40 metabolism in the animal organism]. JAKIMOWSKA K Postepy Biochem; 1958; 4(4):471-9. PubMed ID: 13623519 [No Abstract] [Full Text] [Related]
54. [Pharmacokinetics of drug preparations metabolized by N-acetyltransferase]. Skakun NP Klin Med (Mosk); 1982 Jan; 60(1):24-7. PubMed ID: 6122757 [No Abstract] [Full Text] [Related]
55. [Resistance effect to the para-amino-salicylic acid and the isoniazid phenyl-para-amino-salicylate]. Torning K Prensa Med Argent; 1966; 53(9):1055-9. PubMed ID: 6004190 [No Abstract] [Full Text] [Related]
56. [Comparison of the toxic action of combined isoniazid & the sodium salt of PAS with the toxicity of the PAS salt of isoniazid in the rabbit]. VIALLIER J Therapie; 1959; 14(1):153-4. PubMed ID: 13647432 [No Abstract] [Full Text] [Related]
57. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping. Nair CR; Gupta RC; Varshneya AK; Malik SK Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538 [TBL] [Abstract][Full Text] [Related]
58. [Metabolism of isoniazid in presence of PAS; therapeutic results]. BORSARI G; LAUENER H; FAVEZ G Schweiz Z Tuberc Pneumonol; 1958; 15(4):214-6. PubMed ID: 13602781 [No Abstract] [Full Text] [Related]
59. [The level of p-aminosalicyclic acid in the blood in oral treatment with a calcium-aluminum-p-aminosalicylate]. Mulder RJ; Huizinga T Ned Tijdschr Geneeskd; 1968 Sep; 112(37):1630-4. PubMed ID: 4878452 [No Abstract] [Full Text] [Related]